From 10 – 16 January, Günter Jucho, CFO of Aphaia Pharma AG, will be attending the 43rd annual J. P. Morgan Healthcare Conference in San Francisco. ‘This is certainly the world’s most exciting investor meeting, and this year is particularly interesting because we will be there to learn how the new US government is taking its first steps.’

Participation in the conference is by personal invitation only, and around 8,000 participants are expected: investors, pharmaceutical companies of all sizes, scientists and many others.

The organisers will be paying particular attention to the new Secretary of Health and Human Services, Robert F. Kennedy Jr. and his relationship with the FDA. We will publish our first impressions here in the second half of January.